Download FREE Report Sample
Download Free samplePreterm birth is among the prevalent public health concerns all over the world and has become the primary cause of mortality in children aging below 5 years. To curb the alarming situation, governments including, the Food and Drug Administration (FDA), are showing immediacy in approving drugs for preterm birth prevention and management.
Preterm Birth Prevention and Treatment Market contains market size and forecasts of Preterm Birth Prevention and Treatment in Global, including the following market information:
Global Preterm Birth Prevention and Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Preterm Birth Prevention and Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Progesterone Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Preterm Birth Prevention and Treatment include AMAG Pharmaceuticals, Ferring Pharmaceutical, Teva, Allergan, AbbVie, Aurobindo Pharma, Bayer, Mylan and Pfizer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Preterm Birth Prevention and Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Preterm Birth Prevention and Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Preterm Birth Prevention and Treatment Market Segment Percentages, by Type, 2021 (%)
Progesterone Therapy
Corticosteroid Therapy
Tocolytics Therapy
Antihypertensive Therapy
Magnesium Sulfate Therapy
Other
Global Preterm Birth Prevention and Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Preterm Birth Prevention and Treatment Market Segment Percentages, by Application, 2021 (%)
Hospital
Drugs Stores
Other
Global Preterm Birth Prevention and Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Preterm Birth Prevention and Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Preterm Birth Prevention and Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Preterm Birth Prevention and Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AMAG Pharmaceuticals
Ferring Pharmaceutical
Teva
Allergan
AbbVie
Aurobindo Pharma
Bayer
Mylan
Pfizer
Merck & Co
Novartis
Sanofi
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
